These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


224 related items for PubMed ID: 2217171

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The mechanism of synergistic interaction between anti-interleukin 2 receptor monoclonal antibody and cyclosporine therapy in rat recipients of organ allografts.
    Ueda H, Hancock WW, Cheung YC, Diamantstein T, Tilney NL, Kupiec-Weglinski JW.
    Transplantation; 1990 Oct; 50(4):545-50. PubMed ID: 2219270
    [Abstract] [Full Text] [Related]

  • 5. Pretreatment with cyclosporin A (CyA) and anti-interleukin 2 receptor monoclonal antibody (IL-2R MAb) abrogates the anti-idiotype response in rat recipients of cardiac allografts.
    Tanaka K, Kupiec-Weglinski JW, Hancock WW, Stunkel K, Diamantstein T, Tilney NL.
    Transplant Proc; 1991 Feb; 23(1 Pt 1):281-2. PubMed ID: 1990532
    [No Abstract] [Full Text] [Related]

  • 6. Identification of IL 2R+ T cells and macrophages within rejecting rat cardiac allografts, and comparison of the effects of treatment with anti-IL 2R monoclonal antibody or cyclosporin.
    Hancock WW, Lord RH, Colby AJ, Diamantstein T, Rickles FR, Dijkstra C, Hogg N, Tilney NL.
    J Immunol; 1987 Jan 01; 138(1):164-70. PubMed ID: 3097143
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Agonistic and antagonistic interactions of anti-interleukin 2 receptor monoclonal antibodies in rat recipients of cardiac allografts.
    Kupiec-Weglinski JW, Tilney NL, Stunkel KG, Grutzmann R, van der Meide PH, Di Stefano R, Diamantstein T.
    Transplantation; 1989 Jan 01; 47(1):11-6. PubMed ID: 2463699
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Synergy between cyclosporine and anti-IL-2 receptor monoclonal antibodies in rats. Functional studies of heart and kidney allografts.
    Ueda H, Cheung YC, Masetti P, Diaco M, McCarter M, Kupiec-Weglinski JW, Tilney NL.
    Transplantation; 1991 Sep 01; 52(3):437-42. PubMed ID: 1897014
    [Abstract] [Full Text] [Related]

  • 13. The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts.
    Binder J, Lehmann M, Graser E, Hancock WW, Watschinger B, Onodera K, Sayegh MH, Volk HD, Kupiec-Weglinski JW.
    Transplantation; 1996 Mar 15; 61(5):804-11. PubMed ID: 8607187
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evidence that therapeutic strategies targeted at CD4+ cells modulate accelerated rejection of cardiac allografts in sensitized rats by different mechanisms.
    Sablinski T, Sayegh MH, Kut JP, Milford EL, Tilney NL, Kupiec-Weglinski JW.
    Transplantation; 1992 Aug 15; 54(2):292-6. PubMed ID: 1353914
    [Abstract] [Full Text] [Related]

  • 18. Survival, function, morphology and serological aspects of rat renal allografts. Effect of short-term treatment with cyclosporine A, anti-CD4 and anti-interleukin-2 receptor monoclonal antibodies.
    Steinbrüchel DA, Larsen S, Kristensen T, Starklint H, Koch C, Kemp E.
    APMIS; 1992 Aug 15; 100(8):682-94. PubMed ID: 1520480
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.